The nation’s first drug approved to delay the onset of stage 3 Type 1 diabetes is expected to cost $13,850 per vial, the drugmaker said Nov. 18.
Read the full post on Becker's Hospital Review - Healthcare News
Read the full post on Becker's Hospital Review - Healthcare News